07/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

07/2024

Jul 19, 2024, 22:55 | Blog
Potential of "smart warheads" in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting developments in cancer treatment! Erika…
Jul 19, 2024, 22:53 | Blog
Advancing Sarcoma Research through Anya's Wish project
Children's Cancer Institute shared a post on LinkedIn: "Sarcomas are tumours of the bones, cartilage…
Jul 19, 2024, 22:53 | Blog
iHope Genetic Health Program Launches with SickKids and CHEO
Kate Gardiner, Director of Precision Health and the Regional Genetics Program at CHEO, shared a…
Jul 19, 2024, 22:20 | Insight
Sox4 promoting the resolution of tissue injury in pancreas regeneration and cancer
Luis Arnes, Associate Professor at University of Copenhagen, shared a post on X about a recent…
Jul 19, 2024, 22:19 | Insight
Gautam Mehta summarizes the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki for HER2-mutated NSCLC
FDA oncology shared on X: "OCE's Gautam Mehta and colleagues summarize the FDA accelerated approval…
Jul 19, 2024, 22:19 | Blog
Michael Wang: Strong antitumor synergy between venetoclax and A1155463
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jul 19, 2024, 22:19 | Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
Jul 19, 2024, 17:05 | Insight
Myeloma Paper of the Day, July 19th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Once-weekly KRd56 appears similar to twice-weekly…
Jul 19, 2024, 16:04 | Blog
Attend the 2024 FDA Oncology Center of Excellence Pediatric Advocacy Forum
FDA Oncology shared on X: "Save the date and register to attend the 2024 FDA…
Jul 19, 2024, 15:56 | Insight
Melissa Abel joins NCI Center for Cancer Research as a clinical investigator on the Prostate Cancer team
NCI CCR GU Malignancies shared on X: "The GU Malignancies Branch NCI Center for Cancer…
All: 3004 Posts: 1141 - 1150
Special Coverage